Effect of interleukin-18 on viral myocarditis:: Enhancement of interferon-γ and natural killer cell activity

被引:29
作者
Kanda, T
Tanaka, T
Sekiguchi, K
Seta, Y
Kurimoto, M
McManus, JEW
Nagai, R
Yang, D
McManus, BM
Kobayashi, I
机构
[1] Gunma Univ, Sch Med, Dept Gen Med, Maebashi, Gumma 371, Japan
[2] Gunma Univ, Sch Med, Dept Internal Med 2, Maebashi, Gumma 371, Japan
[3] Hayashibara Biochem Labs Inc, Okayama 7028006, Japan
[4] Univ British Columbia, Dept Pathol & Lab Med, St Pauls Hosp, Vancouver, BC V6T 2B5, Canada
关键词
interferon-gamma; interleukin-18; survival; myocarditis; myocardial necrosis;
D O I
10.1006/jmcc.2000.1242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Encephalomyocarditis virus causes viral myocarditis with myocyte necrosis and inflammatory cell infiltration in mice, Because previous studies have shown that some cytokines prevent the sequelae of myocarditis, we assessed the effect of a newly identified cytokine, interleukin-18 (IL-18), in preventing the sequelae of myocarditis, Murine IL-18 (10 mug/day/mouse) was given peritoneally for 10 days in C3H mice infected with EMC virus. Mice were divided into group IL-18 (infected-treated), saline group (infected-untreated), group IL18-2 (treatment started on day 2), group IL-18-5 (treatment started on day 5). Although the 14-day survival rate in saline group was 20%, that in the group IL-18 increased to 80% (P < 0.05). Either mice in group IL-18-2 or in group IL-18-5 did not survive longer than saline group, The viral titer of the heart on day 3 was lower in group IL-18 compared to the saline group (1.00 <plus/minus> 0.20 log(10) tissue culture infected dose (TCID)(50)/mg wet weight v 1.42 +/- 0.12 log(10). TCID50/mg, n = 3 of each). Mice in group IL-18 had less myocardial necrosis and cellular infiltration than the saline group. The myocardial expression of interferon-gamma (IFN-gamma) mRNA in group IL-18 was significantly (P < 0.05) greater than the saline group on days 1 and 3 after viral inoculation. Circulating IFN-<gamma> was significantly elevated on days 1, 5, and 7, but significantly reduced on day 3, The natural killer cell activities in the spleen on days 1, 3, and 5 were significantly (P < 0.05) greater in group IL-18 than in the saline group (41 <plus/minus> 9% v 10 +/- 6% on dap 3, 4 of each). We conclude that IL-18 reduces the severity of EMC viral myocarditis by inducing cardiac expression of IFN-gamma mRNA and increasing splenic natural killer cell activity. (C) 2000 Academic Press.
引用
收藏
页码:2163 / 2171
页数:9
相关论文
共 20 条
[11]   Myocardial dysfunction in an experimental model of autoimmune myocarditis: Role of IFN-gamma [J].
Leiros, CP ;
Goren, N ;
SterinBorda, L ;
Borda, ES .
NEUROIMMUNOMODULATION, 1997, 4 (02) :91-97
[12]   A MAJOR ROLE OF MACROPHAGE ACTIVATION BY INTERFERON-GAMMA DURING MOUSE HEPATITIS-VIRUS TYPE-3 INFECTION .1. GENETICALLY DEPENDENT RESISTANCE [J].
LUCCHIARI, MA ;
PEREIRA, CA .
IMMUNOBIOLOGY, 1989, 180 (01) :12-22
[13]   Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy [J].
Miric, M ;
Miskovic, A ;
Vasiljevic, JD ;
Keserovic, N ;
Pesic, M .
EUROPEAN HEART JOURNAL, 1995, 16 :150-152
[14]   CLONING OF A NEW CYTOKINE THAT INDUCES IFN-GAMMA PRODUCTION BY T-CELLS [J].
OKAMURA, H ;
TSUTSUI, H ;
KOMATSU, T ;
YUTSUDO, M ;
HAKURA, A ;
TANIMOTO, T ;
TORIGOE, K ;
OKURA, T ;
NUKADA, Y ;
HATTORI, K ;
AKITA, K ;
NAMBA, M ;
TANABE, F ;
KONISHI, K ;
FUKUDA, S ;
KURIMOTO, M .
NATURE, 1995, 378 (6552) :88-91
[15]   Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats [J].
Okura, Y ;
Takeda, K ;
Honda, S ;
Hanawa, H ;
Watanabe, H ;
Kodama, M ;
Izumi, T ;
Aizawa, Y ;
Seki, S ;
Abo, T .
CIRCULATION RESEARCH, 1998, 82 (10) :1035-1042
[16]   Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells [J].
Puren, AJ ;
Fantuzzi, G ;
Gu, Y ;
Su, MSS ;
Dinarello, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :711-721
[17]   Persistent expression of cytokine in the chronic stage of viral myocarditis in mice [J].
Shioi, T ;
Matsumori, A ;
Sasayama, S .
CIRCULATION, 1996, 94 (11) :2930-2937
[18]  
Tsutsui H, 1996, J IMMUNOL, V157, P3967
[19]  
Yamamoto N, 1998, CIRCULATION, V97, P1017
[20]  
YOKOYAMA T, 1991, J PHARMACOL EXP THER, V258, P1114